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SYNOPSIS
Since the height of HIV incidence in the mid-1980s, advances in treatment have delayed progression of HIV infection. As a result, surveillance of AIDS cases alone is no longer sufficient to monitor the current status of the HIV epidemic. At the national level, new HIV diagnoses and progression of these cases to AIDS are used to describe the epidemic. The capacity to monitor the national HIV epidemic has consistently improved over the last several years. An increasing number of states report diagnosed HIV cases to the national surveillance system, allowing data from this system to better represent the national picture. Monitoring the national HIV epidemic depends on a nationwide system using standardized methods of data collection, and establishing such a comprehensive system remains one of the highest priorities for national HIV case surveillance. Surveillance is defined as the ongoing systematic collection, analysis, and interpretation of data on cases of disease for use in the planning, implementation, and evaluation of public health practice. 1 Accurate surveillance data have played a critical role in defining and monitoring communicable disease in the United States, most notably in their contribution to describing the true malaria incidence in the southern United States in the 1940s. 2 Case surveillance for HIV/AIDS has always incorporated all components of the surveillance definition-from data collection to data dissemination. Surveillance data are used at the federal and local level to monitor the spread of HIV infection, to target HIV prevention programs and health-care services, and to allocate funding for HIV prevention and care. 3, 4 In some areas, HIV/AIDS case reports are also used to link persons with HIV infection to prevention and treatment services. In the early 1980s, before the causative agent was known and before a diagnostic test for that causative agent was routinely available, surveillance for the disease caused by HIV infection was limited to monitoring for the end-stage syndrome-opportunistic illnesses characteristic of severe immunosuppression and death from AIDS. 5 Over time, advances in treatment, both prophylaxis for common opportunistic illnesses and highly active antiretroviral treatment (HAART), have delayed progression of HIV infection, particularly when these interventions are started early in the course of infection. 6 Therefore, the focus on end-stage disease no longer accurately monitors the current status of the HIV epidemic. Progression to AIDS now increasingly represents delay in HIV testing, due to lack of access to or motivation for testing, or lack of effective therapy once HIV is diagnosed. The current emphasis of national HIV case surveillance is to monitor and describe new diagnoses of HIV infection, further classified by the presence or absence of AIDS at the time of diagnosis, and therefore to serve as the keystone for integrated HIV surveillance programs.
HISTORY OF HIV CASE SURVEILLANCE

Case reporting
National HIV case surveillance data originate from surveillance programs of local, state, and territorial health departments that monitor new diagnoses of HIV infection. These new diagnoses are classified as early (HIV only) or later-stage HIV disease (AIDS). These programs also monitor the progression of HIV infection to AIDS and to death from HIV or other causes. Most HIV (only) and AIDS cases are initially identified by health departments through routine laboratory reporting of confirmatory HIV antibody, viral detection, and CD4+ T-lymphocyte test results, with completion of case reports occurring through active and passive provider-based reporting. State HIV/AIDS surveillance registries are dynamic; that is, case records are updated over time as additional information is submitted to the health department based on state-mandated reporting regulations for laboratories and providers. These data are collected through ongoing laboratory reporting of HIV-related test results and reports of clinical conditions that represent transition from HIV to AIDS or to death over the life of an HIV-infected patient. After the removal of patient identifiers and assignment of a state case identification number, surveillance programs report new cases and updates to existing cases to the Centers for Disease Control and Prevention (CDC) monthly using established case definitions for surveillance. 3, 7 As our knowledge of HIV infection and the disease caused by it has progressed, so too have the HIV and AIDS case definitions.
Monitoring the spectrum of disease
At the national level, CDC uses information on new HIV diagnoses, including the concurrent diagnosis with or later progression to AIDS, to describe the epidemic according to key demographic and geographic characteristics, and according to HIV transmission category. Surveillance for HIV infection focuses on key sentinel events (Figure 1 ). The first is HIV infection, detected currently through new HIV diagnoses, some of which are further classified as incident infections. New diagnoses are optimally followed by the initial CD41 T-lymphocyte counts and viral load tests that serve as markers of the degree of immunosuppression and of entry into care. Using information included in surveillance case reports, CDC tracks cases of HIV infection on a population basis for progression to AIDS determined by a CD41 T-lymphocyte count level less than 200 cells per microliter or the occurrence of an AIDS-defining illness. Deaths among people with HIV, including deaths from AIDS, are also monitored. By collecting information on these key sentinel events, CDC can use national HIV/AIDS surveillance data to monitor the spectrum of disease including incidence of HIV infection and diagnoses, incidence of AIDS, mortality among HIV-infected people, and HIV prevalence.
In 1993, the AIDS case definition for adolescents and adults was changed to include low CD4+ T-lymphocyte counts and three additional AIDS-defining clinical conditions. 7 This change resulted in a temporary increase in the number of AIDS cases. 8 Soon after, however, AIDS incidence and mortality declined in the mid1990s due to a decline in HIV incidence in the 1980s and the widespread availability of HAART (Figure 2 ). These events highlighted a critical need for national HIV case surveillance. Many states, however, had not yet implemented reporting for HIV infection that had not progressed to AIDS. In 1999, CDC published guidelines for National HIV Case Surveillance. 3 In these guidelines, CDC recommended that states integrate surveillance for HIV infection into their ongoing AIDS surveillance activities. 
Implementation of HIV case reporting
The legal authority to mandate HIV reporting and the methods used for reporting rest with state governments. The reporting of all notifiable infectious diseases other than HIV infection (but including the reporting of AIDS) is conducted in all U.S. jurisdictions using the traditional confidential reporting method. In this method, patient names and relevant disease-specific information are reported to public health departments for purposes of surveillance and disease control activities. Soon after the discovery of HIV as the etiologic agent of AIDS and the availability of diagnostic tests to identify HIV infection, several states implemented HIV infection reporting using the same confidential methods, including the reporting of names to local or state health departments, as used for AIDS. The proposal to conduct HIV case surveillance using this method met with great resistance in other areas, due to concerns at the time over potential breaches in confidentiality and suggested negative impact on HIV-infected people such as stigma or loss of health benefits that could result in delays or avoidance in HIV testing. [9] [10] [11] In the face of this resistance, the implementation of HIV reporting has occurred at different points in time over the epidemic ( Figure 3 ), and using different methods of reporting. These different methods of reporting, still intended to serve as confidential reporting of individual cases, used alternative ways to identify HIV-infected individuals. A similar situation occurred in the early-to mid-1900s as routine public health reporting for other sexually transmitted diseases was recommended. 12 The first states to implement HIV case reporting were Minnesota, Colorado, and Wisconsin in 1985.
As of April 2004, HIV case reporting had been implemented in all states and territories. As of July 2006, 50 areas (45 states and five U.S. territories) have implemented confidential name-based HIV infection reporting as an extension of their AIDS case surveillance system ( Figure 4 ). Of these, 12 areas (including one city) had initially implemented alternative methods but later transitioned to name-based HIV reporting. Of the remaining areas, four states and the District of Columbia conduct code-based reporting; in this method, providers or laboratories construct a coded patient identifier comprising different partial patient identifiers (e.g., initials of last name, number of letters in last name, date of birth, and the last four digits of the Social Security number) and report the case to the health department using this coded patient identifier in place of patient name. One state conducts a hybrid name-to-code-based system; in this system, cases are initially reported to the health department using patient name, but names are removed from the surveillance registry after follow-up to complete the initial case report and appropriate patient referrals.
In its 1999 guidelines, based on evaluation of HIV reporting systems using alternative (non-name-based) methods for conducting confidential HIV case reporting, CDC concluded that confidential name-based HIV/AIDS surveillance systems were most likely to produce quality surveillance data and to serve the public health purposes for which surveillance data are required. A similar conclusion had been reached for the other sexually transmitted diseases, for which these alternative reporting methods had also been attempted. 12 Therefore, CDC advised that state and local surveillance programs use the same confidential name-based approach for HIV surveillance as used for AIDS surveillance nationwide. In July 2005, to achieve the goal of nationwide, high-quality HIV surveillance data, CDC strengthened its official guidance, recommending that all states and territories adopt confidential name-based surveillance systems to report HIV infections. CDC strengthened this guidance for several reasons. Surveillance data collected using the confidential name-based approach have been shown to routinely achieve high levels of accuracy and reliability; HIV surveillance conducted using alternate systems that incorporate coded patient identifiers in place of patient name has not been shown to produce data that are any more reliable or accurate. 13 Evaluations have shown that code-based and name-to-code-based systems can be more expensive and resource-intensive to implement and maintain.
Another reason CDC strengthened this guidance is to prevent duplicate reporting in the national surveillance system. One of CDC's important coordination functions in the national surveillance system is to provide a framework for de-duplication of case reports from different areas. This is accomplished using the recorded date of birth, sex, and soundex (an algorithm-generated code computed locally from the last name that is not unique for each name). CDC routinely produces lists of HIV and AIDS cases for each state for instances where the values for these three data elements match with those from records in other reporting jurisdictions. Surveillance personnel across jurisdictions then communicate to identify situations where multiple reports have occurred on a single case, consistent with established interjurisdictional notification practices. 14, 15 Because identification and elimination of duplicate reports across jurisdictions cannot occur without a standardized means of identifying unique cases, CDC has only accepted surveillance data from areas that include names with reports at the local level. Although these names are used at the local level for public health purposes, they are not sent to CDC at initial case report or at follow-up.
In addition to the use of HIV case surveillance data for disease monitoring and control activities, these data are also scheduled to be incorporated into major federal funds allocation effective October 2006, the beginning of the 2007 federal fiscal year. Currently, two major allocations, Titles I and II, under the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, are based on AIDS cases reported to CDC through routine surveillance. In its 2000 re-authorization of the CARE Act, Congress stated that the cases counted for purposes of Ryan White CARE Act grants shall be cases of HIV disease as reported to and confirmed by the CDC Director rather than cases of AIDS. This shift to the use of HIV disease data is scheduled to occur no later than for the allocations occurring in federal fiscal year 2007. 16 The specifics of this shift are to be determined in the reauthorization of the CARE Act, which was scheduled to occur in the fall of 2005 but has not yet occurred.
CURRENT STATUS OF THE HIV EPIDEMIC
At the end of 2003, CDC estimates that there were between 1,039,000 and 1,185,000 people living with HIV infection in the United States. 17 The landscape of the U.S. HIV epidemic has changed since the start of the epidemic. Initially, gay white men represented a majority of people with AIDS. By July 1982, 95% of cases reported to CDC were among males, and 62% were in non-Hispanic whites. 18 Of the 157,252 cases of HIV infection diagnosed during 2001-2004 and reported in CDC by June 2005 (including those with AIDS diagnosed in the same year) in 33 states with established, confidential name-based reporting, the proportion of cases among women has increased to 29%, and the majority of cases (66%) were among people of color. Although non-Hispanic blacks represented only 13% of the population in these states in the four-year period, they accounted for 51% of cases. 19 In 2004, the rate of new HIV diagnoses among non-Hispanic black females was 21 times higher than in their white counterparts, and the rate among non-Hispanic black males was seven times the rate in white males. Although male/male sexual contact remains the major transmission category, 19 
CURRENT STATUS OF HIV CASE SURVEILLANCE
The ability to monitor the national HIV epidemic has consistently improved over the last several years. Cases from more areas have been incorporated into the national data over time, allowing data from this system to better represent the national picture. The availability of surveillance data on new HIV diagnoses provides the ability to monitor the epidemic in a way that is unaffected by access to antiretroviral treatment. HIV case surveillance data are also more likely to represent new diagnoses and current trends in the epidemic, and are therefore more useful in assessing the effect of prevention activities than AIDS surveillance data. HIV surveillance data are also better able to represent trends among youth, a group in which new HIV diagnoses most likely reflect more recent infections and would not have had the time to progress to AIDS. In people aged 25 years or younger, the period for exposure is restricted by the number of years since these individuals initiated risk behavior; among older people, new HIV diagnoses could represent HIV infections that have been latent for up to a decade or more.
Although more comprehensive national data are becoming available on a yearly basis, some areas with the highest AIDS morbidity-particularly California-have implemented confidential name-based HIV reporting only recently, and do not have surveillance systems mature enough to produce data that can be analyzed for trends. Since the beginning of 2003, 11 areas (California, Connecticut, Delaware, Illinois, Kentucky, Maine, New Hampshire, Oregon, Puerto Rico, Rhode Island, and Washington) and one city (Philadelphia) have switched from alternative methods to name-based reporting for HIV cases, and have recently begun or will soon be submitting HIV case reports to CDC for the first time. Interpretation of data from these recently implemented systems is complex. These areas initially report a large number of HIV cases, many of which were diagnosed before the implementation of HIV reporting. These reports could overestimate the extent of the HIV epidemic in an area unless the actual HIV diagnosis dates are taken into account when interpreting trends.
A challenge to the interpretation of HIV surveillance data, in particular to the analysis of trends over time, is that the latency of HIV infection can be quite long; on average, time from HIV infection to development of AIDS in the absence of treatment takes eight to 10 years. 21, 22 Therefore, changes in the annual number of new HIV diagnoses over time may represent changes in HIV testing behaviors and not simply changes in the number of new infections. For this reason, CDC is implementing the national HIV incidence surveillance system as an expansion of existing HIV case surveillance. With this system, CDC will examine new HIV diagnoses reported to local and state surveillance programs in areas with the largest numbers of newly reported cases, using the Serologic Testing Algorithm for Recent HIV Seroconversion 23 (STARHS) to determine whether new diagnoses are likely to represent new infections in a given population. Statistical adjustments are then applied to extrapolate and produce an overall incidence estimate. Built upon the existing HIV case surveillance infrastructure, the development of the national incidence surveillance system is dependent on a well functioning and comprehensive HIV case surveillance system. 24 An important component of monitoring the epidemic is describing the HIV transmission category for reported cases. Information on HIV exposure, captured by surveillance through identification of specific behavioral risk factors, is used to monitor for emergence of new or unusual transmission routes, monitor trends in the transmission of HIV, target risk reduction efforts to groups affected most heavily by the HIV epidemic, and allocate for and plan prevention programs. Historically, the ascertainment of risk factors for HIV infections was very high, with fewer than 5% of AIDS cases diagnosed in 1985 initially reported to CDC without a risk factor. Risk factor ascertainment has decreased over time for AIDS cases, associated with an increased number of cases over time and with the advent of laboratory reporting leading to more cases initially being reported without risk factors. Ascertainment of HIV risk factors, however, has proven even more challenging for HIV than for AIDS cases. This difficulty in ascertaining risk factors is likely due to a combination of factors, such as limited resources available to follow up the larger proportion of cases initially reported without risk factors and to a decrease in provider elicitation or recording of risk factors in patient records from brief outpatient health-care interactions. 25 In an analysis of the estimated number and percent of HIV/AIDS cases diagnosed 1994-2003 and initially reported to CDC without an identified risk factor from 32 surveillance areas with established HIV surveillance, the success of risk factor ascertainment was lower for non-AIDS HIV cases. Among males, 12% of HIV cases that progressed to AIDS in #12 months were reported without risk factors, compared with 36% of HIV cases that progressed to AIDS in greater than 12 months, and 52% of HIV cases that had not progressed to AIDS. Among women, similar findings were observed: 10% of HIV cases that progressed to AIDS in #12 months and 25% of HIV cases that progressed to AIDS in more than 12 months were initially reported without risk factors, as compared with 65% of HIV cases that had not progressed to AIDS. 26 
EXAMPLES OF USES OF HIV SURVEILLANCE DATA
Estimating HIV prevalence in the United States HIV prevalence cannot be measured directly with precision in the United States for a number of reasons. Not all people with HIV have been diagnosed, and not all states use the standard methods for reporting HIV diagnoses, so such reports cannot be included in the national HIV/AIDS surveillance system. The earliest estimates of HIV prevalence in the United States-including people living with HIV infection who have and have not been diagnosed-have been derived using back-calculation methods based on AIDS incidence and a known HIV incubation distribution. 27 When the advances in treatment disrupted the HIV incubation distribution, and therefore the ability to use AIDS incidence as a reliable predictor for preceding HIV incidence, this method of HIV prevalence estimation was largely abandoned in the United States. Researchers have estimated HIV prevalence using population-based health surveys, but these estimates lack precision. 28 Recently, researchers have shown that HIV surveillance data can be used to more accurately estimate HIV prevalence than AIDS surveillance data alone and have used this finding to modify existing back-calculation methods. [29] [30] [31] Taking advantage of the ever-increasing availability of information on HIV diagnoses before progression to AIDS in the United States, CDC estimated the cumulative HIV incidence using a back-calculation model incorporating a standardized HIV infection to AIDS incubation period, time to first detection of HIV infection, and whether a case was detected as HIV and AIDS concurrently. 17 The model estimated both overall HIV prevalence and the proportion undiagnosed. Using this method, the overall HIV estimated prevalence was 1,039,000 to 1,185,000 at the end of 2003. Of these people living with HIV, an estimated 252,000 to 312,000 (24% to 27%) were undiagnosed. These results demonstrate that HIV/AIDS surveillance data, representing people diagnosed with HIV infection, can be used to provide robust estimates of the overall HIV prevalence in the United States. The accuracy of these estimates will continue to improve as more HIV surveillance data are available to incorporate into the statistical modeling procedures.
Impact of HIV and AIDS surveillance data in describing the epidemic National HIV case surveillance data have also been incorporated with AIDS surveillance data to provide a more complete picture of the HIV epidemic. An examination of HIV and AIDS cases diagnosed 1994-2001, reported from 25 areas with established surveillance systems, showed that more people with newly diagnosed HIV infection were female, non-Hispanic blacks, and of younger ages, than when examining AIDS cases alone.
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Measuring progression from HIV to AIDS Using only AIDS surveillance data, CDC has been able to examine the survival time between an AIDS diagnosis and death. 33, 34 Incorporating HIV diagnosis data, however, allows measurement of the time between HIV and AIDS diagnoses, including a measurement of when those two diagnoses occur concurrently. Surveillance data show that 38% of the HIV cases diagnosed in 2002 reported from areas with established HIV reporting systems progressed to AIDS within one year. 34 A recent analysis, conducted using national HIV/AIDS surveillance data reported to CDC from 25 states with established HIV reporting systems since 1994, examined the period between HIV and AIDS diagnosis-and compared this disease progression time by sex, race/ ethnicity, and HIV transmission category. 35 The analysis showed that progression from HIV to AIDS in three years was more likely among non-Hispanic blacks, men, and older people than non-Hispanic whites, women, and younger people, respectively. This approach provides insight into particular groups that may be testing later in the course of disease, or have less access to appropriate care, such that they are progressing to AIDS more rapidly than other groups.
CONCLUSION
HIV case surveillance data provide critical information about the current state of the epidemic in a way that AIDS surveillance data alone cannot. Our ability to best monitor the HIV epidemic is reliant on having a comprehensive national surveillance system based on standardized methods of data collection. Establishing this comprehensive system is one of the highest priorities for national HIV case surveillance. Significant progress toward this goal has been made, and active efforts are underway to continue improvement. Recently implemented HIV reporting systems are maturing. Therefore, data from these areas are being incorporated into the national system. Dissemination and use of this information for program planning and evaluation will accelerate in the next few years. For example, areas with higher rates of HIV infection diagnosed in advanced stages of disease should be targeted for more innovative HIV testing programs; identified demographic groups or geographic regions that have higher proportions of HIV cases that progress to AIDS could be assessed for barriers to access to care or effective antiretroviral treatment; and demographic or transmission category groups or geographic areas with higher rates of new HIV diagnoses can be targeted with culturally appropriate, proven interventions. [36] [37] [38] [39] Only through a comprehensive national HIV surveillance system can these activities be most effectively conducted.
